Study Evaluating GAP-486 in Non-Sustained Ventricular Tachycardia
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
To determine whether the administration of test article will decrease the occurrence of ventricular arrhythmias in patients who have acute coronary syndrome (unstable angina, ST segment elevated myocardial infarction or myocardial infarction without ST elevation).
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Layout table for eligibility information
Ages Eligible for Study:
18 Years and older (Adult, Older Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Male and female patients, 18 years of age or older, that have experienced an acute ischemic event within 24 hours prior to study entry.
Patients with a documented history of coronary artery disease or left ventricular dysfunction
Patients who have experienced an episode of non-sustained ventricular tachycardia within 24 hours of the index ischemic event
Patients who have had percutaneous coronary intervention (PCI), thrombolytics, or open-heart surgery within 48 hours prior to study entry, or who require it during test article administration
Patients who have taken another antiarrhythmic medication (other than a beta blocker) within 5 half-lives of the start of test article
Patients who have a history of torsades de pointes, long QT syndrome, QTc > 0.50